Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

Phase 2

• Conditions: Aging; Aging Well

• Registration Number: NCT05001646
• Lead Sponsor: TruDiagnostic

Brief Summary

This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-07-27
• Study First Submitted QC: 2021-08-05
• Study First Posted: 2021-08-12
• Status Verified: 2022-03
• Study Start: 2022-03
• Last Update Submitted: 2022-03-10
• Last Update Posted: 2022-03-14
• Primary Completion: 2023-01
• Study Completion: 2023-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• Any sex, gender orientation, and ethnicity
• Between ages 30 and 70
• Must be willing and able to participate in venipuncture, health history and clinical assessments, passive monitoring (Oura ring), and continuous in-home Blushield device usage

Exclusion Criteria

• Significant change in diagnosis and/or treatment of major illness or injury within 2 years prior to screening, e.g., diabetes, cancer, cardiovascular disease, psychiatric condition 2. Any ongoing immune system concerns or immunodeficiency disease
• History of any viral illness in preceding year
• Body mass index (BMI) > 35 kg/m2
• Presence of active infection
• Any other illness, disorder, alcohol or chemical dependence that in the opinion of investigators would render study participation unsuitable
• Unable or unwilling to provide required biological sample
• Unable or unwilling to avoid pregnancy during study period

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Epigenetic Testing	Change from baseline to 12 weeks